Less than a month after Pfizer pulled out of the merger with Allergan, they are in the news again as they close in on two new acquisition targets. Yesterday Pfizer announced an agreement to acquire Anacor Pharmaceuticals for approximately US$ 5.2 billion and have also approached Medivation Inc with an expression of interest in purchasing the company. The approach to Medivation Inc puts Pfizer in a potential bidding battle with Sanofi who less than a week ago went public with an offer of approx. US$ 9.3 billion for Medivation.

Start typing and press Enter to search